Newgreen Supple High Quality Trametes Robiniophila Extract Ear Polysaccharide Powder
Product Description
Trametes Robiniophila una e fungis medicinalibus in Sinis momenti est. Eius elementa chemica maxime polysaccharides, steroides et alkaloidas continent. Trametes Robiniophila late adhibita est in adjuvante curatione cancri pectoris, cancer jecoris, cancer pulmonis, cancer gastrici et aliorum tumorum malignorum. Eius mechanismus actionis includit inhibendo incrementum et multiplicationem cellularum tuberculorum, invasionem et metastasim, angiogenesis, apoptosin cellularum tumoris et immunitatem inducens.
COA：
| Product nomen: | Auris Polysaccharide | Date Test: | 2024-06-19 |
| Batch No.: | NG24061801 | OPIFICIUM Date: | 2024-06-18 |
| Quantitas: | 2500kg | Expirata Date: | 2026-06-17 |
| ITEMS | VEXILLUM | Effectus |
| Aspectus | Brown Powder | Conformare |
| Odor | Proprium | Conformare |
| Sapor | Proprium | Conformare |
| Assay | ≥30.0% | 30.6% |
| Cinis Content | ≤0.2. | 0.15% |
| Metalla gravis | ≤10ppm | Conformare |
| As | ≤0.2ppm | <0.2 ppm |
| Pb | ≤0.2ppm | <0.2 ppm |
| Cd | ≤0.1ppm | <0.1 ppm |
| Hg | ≤0.1ppm | <0.1 ppm |
| Totalis comitis Plate | ≤1,000 CFU/g | <150 CFU/g |
| Fingunt & Yeast | ≤50 CFU/g | <10 CFU/g |
| E. Coll | ≤10 MPN/g | <10 MPN/g* |
| Salmonella | Negative | Non Results |
| Staphylococcus Aureus | Negative | Non Results |
| conclusio | Specificationem conformare postulationi. | |
| Repono | Repone in loco frigido, sicco et ventilato loco. | |
| Shelf Life | Biennium si signatum reponunt a recto sole lumen et umorem. | |
Munus:
Studia pharmacologica moderna ostenderunt Trametes Robiniophila/Sophora auriculata posse anti-tumorem effectus exercere, inhibendo incrementum et multiplicationem cellularum tumoris, apoptosin cellularum tumoris inducendo, inhibendo angiogenesim, inhibitionem et metastasim cellularum tumoris inhibendo varias expressiones. oncogenes et tumor suppressoris genesis, immunitas corporis emendans, resistentia pharmaci cellulis tumoris et sic porro. Unius eius sapor medicamenta et extracta ut cancer medicamenta adjuvant probata sunt in Sinis anno 1997 ad curationem cancri iecoris primi.
Applicatio:
Trametes Robiniophila certos habet effectus anti-tumorem in cancer pectus, cancer pulmonis, cancer ventriculi, cancer hepatis, cancer prostaticus, cancer pancreaticus, cancer renis, leukemia lymphoblastic acuta et sclerosis nodulares, et scuta eius numerosa sunt, varias meatus tumoris occursus ac progressus. In praxi clinica, Trametes Robiniophila effectum therapeuticum habet in variis tumoribus malignis cum parva toxicitate, quae progressionem aegrorum tumoris differre potest, qualitatem vitae meliorem et salutem aegrorum prorogare et bonam applicationem prospectum habet.
Sarcina & Delivery
